Cargando…

Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury

BACKGROUND: Ischemia–reperfusion injury following ST‐segment–elevation myocardial infarction (STEMI) is a leading determinant of clinical outcome. In experimental models of myocardial ischemia, succinate accumulation leading to mitochondrial dysfunction is a major cause of ischemia–reperfusion injur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohlhauer, Matthias, Dawkins, Sam, Costa, Ana S. H., Lee, Regent, Young, Timothy, Pell, Victoria R., Choudhury, Robin P., Banning, Adrian P., Kharbanda, Rajesh K., Saeb‐Parsy, Kourosh, Murphy, Michael P., Frezza, Christian, Krieg, Thomas, Channon, Keith M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015393/
https://www.ncbi.nlm.nih.gov/pubmed/29626151
http://dx.doi.org/10.1161/JAHA.117.007546
_version_ 1783334402502164480
author Kohlhauer, Matthias
Dawkins, Sam
Costa, Ana S. H.
Lee, Regent
Young, Timothy
Pell, Victoria R.
Choudhury, Robin P.
Banning, Adrian P.
Kharbanda, Rajesh K.
Saeb‐Parsy, Kourosh
Murphy, Michael P.
Frezza, Christian
Krieg, Thomas
Channon, Keith M.
author_facet Kohlhauer, Matthias
Dawkins, Sam
Costa, Ana S. H.
Lee, Regent
Young, Timothy
Pell, Victoria R.
Choudhury, Robin P.
Banning, Adrian P.
Kharbanda, Rajesh K.
Saeb‐Parsy, Kourosh
Murphy, Michael P.
Frezza, Christian
Krieg, Thomas
Channon, Keith M.
author_sort Kohlhauer, Matthias
collection PubMed
description BACKGROUND: Ischemia–reperfusion injury following ST‐segment–elevation myocardial infarction (STEMI) is a leading determinant of clinical outcome. In experimental models of myocardial ischemia, succinate accumulation leading to mitochondrial dysfunction is a major cause of ischemia–reperfusion injury; however, the potential importance and specificity of myocardial succinate accumulation in human STEMI is unknown. We sought to identify the metabolites released from the heart in patients undergoing primary percutaneous coronary intervention for emergency treatment of STEMI. METHODS AND RESULTS: Blood samples were obtained from the coronary artery, coronary sinus, and peripheral vein in patients undergoing primary percutaneous coronary intervention for acute STEMI and in control patients undergoing nonemergency coronary angiography or percutaneous coronary intervention for stable angina or non‐STEMI. Plasma metabolites were analyzed by targeted liquid chromatography and mass spectrometry. Metabolite levels for coronary artery, coronary sinus, and peripheral vein were compared to derive cardiac and systemic release ratios. In STEMI patients, cardiac magnetic resonance imaging was performed 2 days and 6 months after primary percutaneous coronary intervention to quantify acute myocardial edema and final infarct size, respectively. In total, 115 patients undergoing acute STEMI and 26 control patients were included. Succinate was the only metabolite significantly increased in coronary sinus blood compared with venous blood in STEMI patients, indicating cardiac release of succinate. STEMI patients had higher succinate concentrations in arterial, coronary sinus, and peripheral venous blood than patients with non‐STEMI or stable angina. Furthermore, cardiac succinate release in STEMI correlated with the extent of acute myocardial injury, quantified by cardiac magnetic resonance imaging. CONCLUSION: Succinate release by the myocardium correlates with the extent of ischemia.
format Online
Article
Text
id pubmed-6015393
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60153932018-07-05 Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury Kohlhauer, Matthias Dawkins, Sam Costa, Ana S. H. Lee, Regent Young, Timothy Pell, Victoria R. Choudhury, Robin P. Banning, Adrian P. Kharbanda, Rajesh K. Saeb‐Parsy, Kourosh Murphy, Michael P. Frezza, Christian Krieg, Thomas Channon, Keith M. J Am Heart Assoc Original Research BACKGROUND: Ischemia–reperfusion injury following ST‐segment–elevation myocardial infarction (STEMI) is a leading determinant of clinical outcome. In experimental models of myocardial ischemia, succinate accumulation leading to mitochondrial dysfunction is a major cause of ischemia–reperfusion injury; however, the potential importance and specificity of myocardial succinate accumulation in human STEMI is unknown. We sought to identify the metabolites released from the heart in patients undergoing primary percutaneous coronary intervention for emergency treatment of STEMI. METHODS AND RESULTS: Blood samples were obtained from the coronary artery, coronary sinus, and peripheral vein in patients undergoing primary percutaneous coronary intervention for acute STEMI and in control patients undergoing nonemergency coronary angiography or percutaneous coronary intervention for stable angina or non‐STEMI. Plasma metabolites were analyzed by targeted liquid chromatography and mass spectrometry. Metabolite levels for coronary artery, coronary sinus, and peripheral vein were compared to derive cardiac and systemic release ratios. In STEMI patients, cardiac magnetic resonance imaging was performed 2 days and 6 months after primary percutaneous coronary intervention to quantify acute myocardial edema and final infarct size, respectively. In total, 115 patients undergoing acute STEMI and 26 control patients were included. Succinate was the only metabolite significantly increased in coronary sinus blood compared with venous blood in STEMI patients, indicating cardiac release of succinate. STEMI patients had higher succinate concentrations in arterial, coronary sinus, and peripheral venous blood than patients with non‐STEMI or stable angina. Furthermore, cardiac succinate release in STEMI correlated with the extent of acute myocardial injury, quantified by cardiac magnetic resonance imaging. CONCLUSION: Succinate release by the myocardium correlates with the extent of ischemia. John Wiley and Sons Inc. 2018-04-06 /pmc/articles/PMC6015393/ /pubmed/29626151 http://dx.doi.org/10.1161/JAHA.117.007546 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Kohlhauer, Matthias
Dawkins, Sam
Costa, Ana S. H.
Lee, Regent
Young, Timothy
Pell, Victoria R.
Choudhury, Robin P.
Banning, Adrian P.
Kharbanda, Rajesh K.
Saeb‐Parsy, Kourosh
Murphy, Michael P.
Frezza, Christian
Krieg, Thomas
Channon, Keith M.
Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury
title Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury
title_full Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury
title_fullStr Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury
title_full_unstemmed Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury
title_short Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury
title_sort metabolomic profiling in acute st‐segment–elevation myocardial infarction identifies succinate as an early marker of human ischemia–reperfusion injury
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015393/
https://www.ncbi.nlm.nih.gov/pubmed/29626151
http://dx.doi.org/10.1161/JAHA.117.007546
work_keys_str_mv AT kohlhauermatthias metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT dawkinssam metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT costaanash metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT leeregent metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT youngtimothy metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT pellvictoriar metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT choudhuryrobinp metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT banningadrianp metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT kharbandarajeshk metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT saebparsykourosh metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT murphymichaelp metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT frezzachristian metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT kriegthomas metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury
AT channonkeithm metabolomicprofilinginacutestsegmentelevationmyocardialinfarctionidentifiessuccinateasanearlymarkerofhumanischemiareperfusioninjury